Works matching DE "DOCETAXEL"

Results: 3428
    1
    2
    3

    Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: EuroGemDoce group results.

    Published in:
    BJU International, 2025, v. 135, n. 6, p. 969, doi. 10.1111/bju.16645
    By:
    • Scilipoti, Pietro;
    • Longoni, Mattia;
    • de Angelis, Mario;
    • Zaurito, Paolo;
    • Massiet, Albane;
    • Dutto, Daniele;
    • Soria, Francesco;
    • Álvarez‐Maestro, Mario;
    • Bazán, Alfredo Aguilera;
    • Pradere, Benjamin;
    • Klatte, Tobias;
    • Contieri, Roberto;
    • Hurle, Rodolfo;
    • Krajewski, Wojciech;
    • Subiela, José Daniel;
    • Pichler, Renate;
    • Szostek, Aleksandra;
    • Marcq, Gautier;
    • Elena, José Luis Rodríguez;
    • Aranda, Javier
    Publication type:
    Article
    4
    5
    6
    7

    Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 652, doi. 10.3390/ph18050652
    By:
    • Hetta, Helal F.;
    • Alqifari, Saleh F.;
    • Alshehri, Khaled;
    • Alhowiti, Amirah;
    • Alharbi, Saud S.;
    • Mirghani, Hyder;
    • Alrasheed, Tariq;
    • Mostafa, Mohamed E. A.;
    • Sheikh, Mohammed;
    • Elodemi, Mahmoud;
    • Alhumaid, Sultan A.;
    • Ramadan, Yasmin N.;
    • Abd Ellah, Noura H.;
    • Sayad, Reem
    Publication type:
    Article
    8

    Real-world data on the efficacy and toxicity of induction chemotherapy in locally advanced nasopharyngeal carcinoma in a non-endemic population.

    Published in:
    Ecancermedicalscience, 2025, v. 19, n. 1824-1915, p. 1, doi. 10.3332/ecancer.2025.1832
    By:
    • Hidalgo Filho, Cassio Murilo;
    • Berlingieri Polho, Gabriel;
    • Augusto Moreira, Otavio;
    • de Oliveira Andrade, Matheus;
    • Cruz Parrela, Vinicius;
    • Ricucci Shinkado, Yumi;
    • de Almeida Robatto, Amanda Acioli;
    • Lazar Neto, Felippe;
    • Freitas, Ana Julia;
    • Teixeira Souza, Aurelio;
    • de Castro Junior, Gilberto;
    • Perez Mak, Milena
    Publication type:
    Article
    9

    Value in Oncology.

    Published in:
    Oncology (08909091), 2014, v. 28, n. 7, p. 643
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study.

    Published in:
    International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 62, doi. 10.1007/s10147-011-0344-x
    By:
    • Shimabukuro, Tomoyuki;
    • Sakano, Shigeru;
    • Matsuda, Kenji;
    • Kamiryo, Yoriaki;
    • Yamamoto, Norio;
    • Kaneda, Yoshitaka;
    • Nasu, Takahito;
    • Baba, Yoshikazu;
    • Suga, Akinobu;
    • Yamamoto, Mitsutaka;
    • Aoki, Akihiko;
    • Takai, Kimio;
    • Yoshihiro, Satoru;
    • Konishi, Motohiko;
    • Imoto, Katsuhiko;
    • Matsuyama, Hideyasu
    Publication type:
    Article
    43
    44
    45
    46

    Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 204, doi. 10.1007/s10147-011-0275-6
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Maita, Shinya;
    • Obara, Takashi;
    • Numakura, Kazuyuki;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Habuchi, Tomonori
    Publication type:
    Article
    47
    48
    49
    50